Akebia Therapeutics Inc (AKBA)

05:13 AM

Improved Revenues Required Before Akebia Therapeutics, Inc. (NASDAQ:AKBA) Stock's 30% Jump Looks Justified - Simply Wall St

05:13 AM

Jan 21, 2025

Akebia Therapeutics (NASDAQ:AKBA) Stock Price Up 10.9%Should You Buy? - MarketBeat

Jan 21, 2025

Jan 20, 2025

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Shares Bought by Barclays PLC - MarketBeat

Jan 20, 2025

Jan 18, 2025

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listi - GuruFocus.com

Jan 18, 2025

Jan 18, 2025

Equities Analysts Issue Forecasts for AKBA FY2024 Earnings - Defense World

Jan 18, 2025

Jan 18, 2025

What is HC Wainwright's Forecast for AKBA FY2024 Earnings? - MarketBeat

Jan 18, 2025

Jan 17, 2025

Brokers Set Expectations for AKBA FY2024 Earnings - MarketBeat

Jan 17, 2025

Jan 17, 2025

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Sees Significant Increase in Short Interest - MarketBeat

Jan 17, 2025

Jan 17, 2025

Analysts Offer Predictions for AKBA FY2029 Earnings - MarketBeat

Jan 17, 2025

Jan 16, 2025

Brokers Issue Forecasts for AKBA FY2029 Earnings - MarketBeat

Jan 16, 2025

Jan 16, 2025

Akebia Therapeutics (NASDAQ:AKBA) Earns Buy Rating from HC Wainwright - Defense World

Jan 16, 2025

Jan 15, 2025

Akebia Therapeutics (NASDAQ:AKBA) Rating Lowered to Sell at StockNews.com - MarketBeat

Jan 15, 2025

Jan 14, 2025

H.C. Wainwright optimistic on Akebia shares despite risks to commercial opportunity - Investing.com Nigeria

Jan 14, 2025

Jan 14, 2025

HC Wainwright Reiterates "Buy" Rating for Akebia Therapeutics (NASDAQ:AKBA) - MarketBeat

Jan 14, 2025

Jan 14, 2025

Akebia announces ‘multiple positive business updates’ - Yahoo Finance

Jan 14, 2025

Jan 14, 2025

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Shares Sold by Jane Street Group LLC - Defense World

Jan 14, 2025

Jan 13, 2025

Vafseo tablets start U.S. shipment, Akebia plans Phase 3 trial - Investing.com India

Jan 13, 2025

Jan 13, 2025

Akebia Therapeutics Announces Multiple Positive Business Updates - citybiz

Jan 13, 2025

Jan 13, 2025

Akebia's Vafseo Launch Secures Coverage for Nearly All U.S. Dialysis Patients, 99% of Doctors Show Interest - StockTitan

Jan 13, 2025

Jan 10, 2025

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Marketscreener.com

Jan 10, 2025

Jan 08, 2025

Akebia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Kilgore News Herald

Jan 08, 2025

Jan 07, 2025

Akebia Therapeutics (NASDAQ:AKBA) Upgraded at StockNews.com - MarketBeat

Jan 07, 2025

Jan 05, 2025

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Stock Holdings Lifted by Barclays PLC - Defense World

Jan 05, 2025

Jan 04, 2025

Geode Capital Management LLC Has $6.28 Million Position in Akebia Therapeutics, Inc. (NASDAQ:AKBA) - Defense World

Jan 04, 2025

Jan 03, 2025

New Strong Sell Stocks for January 3rd - Yahoo Finance

Jan 03, 2025

Jan 02, 2025

Akebia Therapeutics Awards Inducement Stock Options to New Employee at $1.90 Per Share - StockTitan

Jan 02, 2025

Dec 31, 2024

Short Interest in Akebia Therapeutics, Inc. (NASDAQ:AKBA) Expands By 21.7% - Defense World

Dec 31, 2024

Dec 31, 2024

Akebia Therapeutics (NASDAQ:AKBA) Stock Rating Lowered by StockNews.com - MarketBeat

Dec 31, 2024

Dec 30, 2024

State Street Corp Purchases 683,287 Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) - MarketBeat

Dec 30, 2024

Dec 30, 2024

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Shares Purchased by State Street Corp - Defense World

Dec 30, 2024

Dec 29, 2024

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Short Interest Update - MarketBeat

Dec 29, 2024

Dec 27, 2024

Akebia Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights - GuruFocus.com

Dec 27, 2024

Dec 21, 2024

Wellington Management Group LLP Takes $534,000 Position in Akebia Therapeutics, Inc. (NASDAQ:AKBA) - MarketBeat

Dec 21, 2024

Dec 20, 2024

High Growth Tech Stocks To Watch In December 2024 - Simply Wall St

Dec 20, 2024

Dec 20, 2024

Investors in Akebia Therapeutics (NASDAQ:AKBA) have unfortunately lost 73% over the last five years - Yahoo Finance

Dec 20, 2024

Dec 19, 2024

CMS Grants TDAPA Reimbursement for Vafseo® (vadadustat) beginning January 1, 2025 - The Eastern Progress Online

Dec 19, 2024

Dec 18, 2024

Akebia Therapeutics CEO to Present Vafseo Launch Updates at J.P. Morgan Healthcare Conference 2024 - StockTitan

Dec 18, 2024

Dec 17, 2024

Cyclerion Strikes $560M Milestone Deal with Akebia, Completes Portfolio Monetization Strategy - StockTitan

Dec 17, 2024

Dec 13, 2024

Akebia Therapeutics (NASDAQ:AKBA) Upgraded by StockNews.com to Hold Rating - MarketBeat

Dec 13, 2024

Dec 11, 2024

Akebia Therapeutics to Present at the Jefferies London Healthcare Conference - The Eastern Progress Online

Dec 11, 2024

Dec 08, 2024

Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference - Kilgore News Herald

Dec 08, 2024

Dec 07, 2024

Akebia Therapeutics to Present at Upcoming Investor Conferences - The Eastern Progress Online

Dec 07, 2024

Dec 05, 2024

New Strong Sell Stocks for December 5th - Yahoo Finance

Dec 05, 2024

Dec 04, 2024

Akebia Therapeutics (FRA:AX9) EBITDA : €4.0 Mil (TTM As of Sep. 2024) - GuruFocus.com

Dec 04, 2024